BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $961,000 | -19.1% | 14,971 | -2.3% | 0.13% | -3.6% |
| Q1 2022 | $1,188,000 | -11.9% | 15,328 | -2.5% | 0.14% | -4.8% |
| Q4 2021 | $1,349,000 | +5.3% | 15,720 | -1.3% | 0.14% | -3.3% |
| Q3 2021 | $1,281,000 | 0.0% | 15,933 | +0.1% | 0.15% | +2.7% |
| Q2 2021 | $1,281,000 | -3.8% | 15,925 | +0.9% | 0.15% | -12.6% |
| Q1 2021 | $1,331,000 | +4.0% | 15,788 | -1.1% | 0.17% | -2.3% |
| Q4 2020 | $1,280,000 | -4.5% | 15,960 | -4.3% | 0.17% | -12.3% |
| Q3 2020 | $1,341,000 | -5.8% | 16,684 | +0.9% | 0.20% | -13.3% |
| Q2 2020 | $1,424,000 | +2.4% | 16,543 | -3.5% | 0.22% | -14.8% |
| Q1 2020 | $1,391,000 | -5.6% | 17,135 | -2.8% | 0.26% | +26.3% |
| Q4 2019 | $1,474,000 | -4.5% | 17,628 | -0.1% | 0.21% | -9.9% |
| Q3 2019 | $1,543,000 | +4.2% | 17,645 | -2.4% | 0.23% | +5.0% |
| Q2 2019 | $1,481,000 | -7.5% | 18,087 | -8.2% | 0.22% | -9.4% |
| Q1 2019 | $1,601,000 | +17.9% | 19,701 | -4.6% | 0.24% | +7.0% |
| Q4 2018 | $1,358,000 | -14.6% | 20,643 | +0.0% | 0.23% | +3.2% |
| Q3 2018 | $1,590,000 | +2.2% | 20,636 | -2.1% | 0.22% | -1.8% |
| Q2 2018 | $1,556,000 | +13.6% | 21,078 | +0.0% | 0.22% | +16.0% |
| Q1 2018 | $1,370,000 | -4.1% | 21,071 | -4.7% | 0.19% | -1.0% |
| Q4 2017 | $1,429,000 | +2.2% | 22,115 | -0.8% | 0.20% | -2.0% |
| Q3 2017 | $1,398,000 | +2.8% | 22,290 | -0.8% | 0.20% | 0.0% |
| Q2 2017 | $1,360,000 | +11.3% | 22,470 | -4.7% | 0.20% | +9.9% |
| Q1 2017 | $1,222,000 | +13.5% | 23,570 | -3.0% | 0.18% | +7.1% |
| Q4 2016 | $1,077,000 | -7.2% | 24,295 | -0.4% | 0.17% | -5.6% |
| Q3 2016 | $1,161,000 | +1.0% | 24,395 | -4.1% | 0.18% | +1.1% |
| Q2 2016 | $1,150,000 | +16.2% | 25,445 | +5.5% | 0.18% | +14.8% |
| Q1 2016 | $990,000 | +5.9% | 24,120 | -1.6% | 0.16% | +8.4% |
| Q4 2015 | $935,000 | +10.8% | 24,520 | -4.6% | 0.14% | +2.9% |
| Q3 2015 | $844,000 | -55.5% | 25,695 | -5.4% | 0.14% | -51.1% |
| Q2 2015 | $1,898,000 | -2.3% | 27,149 | -4.3% | 0.28% | -1.0% |
| Q1 2015 | $1,943,000 | -8.8% | 28,377 | -2.4% | 0.29% | -11.7% |
| Q4 2014 | $2,131,000 | -9.4% | 29,082 | -11.3% | 0.32% | -11.2% |
| Q3 2014 | $2,352,000 | +5.8% | 32,782 | +6.6% | 0.37% | +4.0% |
| Q2 2014 | $2,223,000 | +2.7% | 30,754 | +4.5% | 0.35% | -3.3% |
| Q1 2014 | $2,165,000 | +28.9% | 29,429 | +21.8% | 0.36% | +24.7% |
| Q4 2013 | $1,679,000 | +10.5% | 24,154 | +4.4% | 0.29% | +1.7% |
| Q3 2013 | $1,519,000 | +10.2% | 23,129 | +16.2% | 0.29% | +2.1% |
| Q2 2013 | $1,378,000 | – | 19,897 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |